Posterior reversible encephalopathy syndrome: Another manifestation of CNS SLE?

Lupus

Volumn 16, Issue 6, 2007, Pages 436-443

  Ishimori, M L ^a,c   Pressman, B D ^b   Wallace, D J ^a   Weisman, M H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Section of Neuroradiology and Head and Neck Radiology   (United States)

^c NONE   (United States)

Author keywords

Immunosuppressive therapy; Magnetic resonance imaging; Posterior reversible encephalopathy syndrome; Seizure; Systemic lupus erythematosus

Indexed keywords

ANTIBIOTIC AGENT; CYCLOPHOSPHAMIDE; DEXAMETHASONE; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; STEROID;

ADULT; ARTICLE; BRAIN DISEASE; CASE REPORT; CENTRAL NERVOUS SYSTEM; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DRUG DOSE INCREASE; ENCEPHALITIS; FEMALE; GLOMERULONEPHRITIS; HUMAN; HYPERTENSION; KIDNEY DISEASE; MALE; MEDICAL RECORD; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PNEUMONIA; PRIORITY JOURNAL; STROKE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; BRAIN DISEASES; FEMALE; HUMANS; HYPERTENSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY DISEASES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; REMISSION, SPONTANEOUS; SYNDROME;

EID: 34547200564     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203307078682     Document Type: Article

References (51)

1. ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999; 42: 599-608.
2. Hinchey J, Chaves C, Appignani B et al. A reversible posterior encephalopathy syndrome. New Engl J Med 1996; 334: 494-500.
3. Ay H, Buonanno FS, Schaefer PW et al. Posterior leukoencephalopathy without severe hypertension: utility of diffusion-weighted MRI. Neurology 1998; 51: 1369-1376.
4. Casey SO, Sampaio RC, Michel E, Truwit CL. Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions. AJNR Am J Neuroradiol 2000; 21: 1199-1206.
5. Delanty N, Vaughan C, Frucht S et al. Erythropoietin-associated hypertensive posterior leukoencephalopathy. Neurology 1997; 49: 686-689.
6. Dy GK, Swaroop VS. 31-Year-old woman with confusion and labile behavior. Mayo Clin Proc 2002; 77: 557-560.
7. Magnano MD, Bush TM, Herrera I et al. Reversible posterior leukoencephalopathy in patients with systemic lupus erythematosus. Semin Arthritis Rheum 2006; 35: 396-402.
8. Mavragani CP, Vlachoyiannopoulos PG, Kosmas N et al. A case of reversible posterior leucoencephalopathy syndrome after rituximab infusion. Rheumatology 2004; 43: 1450-1451.
9. Min L, Zwerling J, Ocava LC et al. Reversible posterior leukoencephalopathy in connective tissue diseases. Semin Arthritis Rheum 2006; 35: 388-395.
10. Mukherjee P, McKinstry RC. Reversible posterior leukoencephalopathy syndrome: evaluation with diffusion-tensor imaging. Radiology 2001; 219: 756-765.
11. Pasupuleti DV, Miranda M, Vattipally V. Case report: posterior reversible encephalopathy syndrome. Am Fam Physician 2005; 72: 2430.
12. Pavlakis SG, Frank Y, Kalina P et al. Occipital parietal encephalopathy: a new name for an old syndrome. Pediatr Neurol 1997; 16: 145-148.
13. Primavera A, Audenino D, Mavilio N et al. Reversible posterior encephalopathy syndrome in systemic lupus and vasculitis. Ann Rheum Dis 2001; 60: 534-537.
14. Schwartz RB, Mulkern RV, Gudbjartsson H et al. Diffusion-weighted MR imaging in hypertensive encephalopathy: clues to pathogenesis. AJNR Am J Neuroradiol 1998; 19: 859-862.
15. Shin KC, Choi HJ, Bae YD et al. Reversible posterior encephalopathy syndrome in systemic lupus erythematosus with thrombocytopenia treated with cyclosporine. J Clin Rheumatol 2005; 11: 164-166.
16. Thaipisuttikul I, Phanthumchinda K. Recurrent reversible posterior leukoencephalopathy in a patient with systemic lupus erythematosus. J Neurol 2005; 252: 230-231.
17. Yong PFK, Hamour SMA, Burns A. Reversible posterior leukoencephalopathy in a patient with systemic sclerosis/systemic lupus erythematosus overlap syndrome. Nephrol Dial Transplant 2003; 18: 2660-2662.
18. Kur JK, Esdaile JM. Posterior reversible encephalopathy syndrome - an underrecognized manifestation of systemic lupus erythematosus. J Rheumatol 2006; 33: 2178-2183.
19. Covarrubias DJ, Luetmer PH, Campeau NG. Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted images. AJNR Am J Neuroradiol 2002; 23: 1038-1048.
20. Dillon WP, Rowley H. The reversible posterior cerebral edema syndrome. AJNR Am J Neuroradiol 1998; 19: 591.
21. Stott VL, Hurrell MA, Anderson TJ. Reversible posterior leukoencephalopathy syndrome: a misnomer reviewed. Intern Med J 2005; 35: 83-90.
22. Schwartz RB, Jones KM, Kalina P et al. Hypertensive encephalopathy: findings on CT, MR imaging and SPECT imaging in 14 cases. AJR Am J Roentgenol 1992; 159: 379-383.
23. Peterson PL, Axford JS, Isenberg D. Imaging in CNS lupus. Best Pract Res Clini Rheumatol 2005; 19: 727-739.
24. Orrison WWJ. Neuroimaging. Philadelphia: WB Saunders Company, 2000.
25. Yang Q, Tress BM, Barber PA et al. Serial study of apparent diffusion coefficient and anisotropy in patients with acute stroke. Stroke 1999; 30: 2382-2390.
26. Lamy C, Oppenheim C, Meder JF et al. Neuroimaging in posterior reversible encephalopathy syndrome. J Neuroimaging 2004; 14: 89-96.
27. Provenzale JM, Petrella JR, Cruz LCHJ et al. Quantitative assessment of diffusion abnormalities in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol 2001; 22: 1455-1461.
28. Schaefer PW, Buonanno FS, Gonzalez RG et al. Diffusion-weighted imaging discriminates between cytotoxic and vasogenic edema in a patient with eclampsia. Stroke 1997; 28: 1082-1085.
29. Govoni M, Castellino G, Padovan M et al. Recent advances and future perspective in neuroimaging in neuropsychiatric systemic lupus erythematosus. Lupus 2004; 13: 149-158.
30. Henderson RD, Rajah T, Nicol AJ et al. Posterior leukoencephalopathy following intrathecal chemotherapy with MRA-documented vasospasm. Neurology 2003; 60: 326-328.
31. Sanna G, Bertolaccini ML, Cuadrado MJ et al. Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with anti-phospholipid antibodies. J Rheumatol 2003; 31: 985-992.
32. Stimmler MM, Coletti PM, Quismorio FPJ. Magnetic resonance imaging of the brain in neuropsychiatric systemic lupus erythematosus. Semin Arthritis Rheum 1993; 22: 335-349.
33. Sibbitt WLJ, Sibbitt RR, Griffey RH et al. Magnetic resonance and computed tomographic imaging in the evaluation of acute neuropsychiatric disease in systemic lupus erythematosus. Ann Rheum Dis 1989; 48: 1014-1022.
34. Jennings JE, Sundgren PC, Attwood J et al. Value of MRI of the brain in patients with systemic lupus erythematosus and neurologic disturbance. Neuroradiology 2004; 46: 15-21.
35. McCune WJ, MacGuire A, Aisen A et al. Identification of brain lesions in neuropsychiatric systemic lupus erythematosus by magnetic resonance scanning. Arthritis Rheum 1988; 31: 159-166.
36. Graham JW, Jan W. MRI and the brain in systemic lupus erythematosus. Lupus 2002; 12: 891-896.
37. Abreu MR, Jakosky A, Flogerini M et al. Neuropsychiatric systemic lupus erythematosus: correlation of brain MR imaging. J Clin Imaging 2005; 29: 215-221.
38. Ainala H, Dastidar P, Loukkola J et al. Cerebral MRI abnormalities and their association with neuropsychiatric manifestations in SLE: a population-based study. Scand J Rheumatol 2005; 34: 376-382.
39. Sibbitt WLJ, Schmidt PJ, Hart BL et al. Fluid attenuated inversion recovery (FLAIR) in neuropsychiatric systemic lupus erythematosus. J Rheumatol 2003; 30: 1983-1989.
40. Sundgren PC, Jennings JE, Attwood JT et al. MRI and sD-CSI MR spectroscopy of the brain in the evaluation of patients with acute onset of neuropsychiatric systemic lupus erythematosus. Neuroradiology 2005; 47: 576-585.
41. Bosma GP, Huizenga TW, Mooijaart SP et al. Abnormal brain diffusivity in patients with neuropsychiatric systemic lupus erythematosus. AJNR Am J Neuroradiol 2003; 24: 850-854.
42. Ito Y, Niwa H, Iida T et al. Post-transfusion reversible posterior leukoencephalopathy. Neurology 1997; 49: 1174-1175.
43. Doss-Esper CE, Singhal AB, Smith MS et al. Reversible posterior leukoencephalopathy, cerebral vasoconstriction, and strokes after intravenous immune globulin therapy in Guillain-Barre syndrome. J Neuroimaging 2005; 15: 188-192.
44. Finsterer J, Schlager T, Kopsa W et al. Nitroglycerin-aggravated preeclamptic posterior reversible encephalopathy syndrome (PRES). Neurology 2003; 61: 715-716.
45. Glusker P, Recht L, Lane B. Reversible posterior leukoencephalopathy syndrome and bevacizumab. New Engl J Med 2006; 354: 980-981.
46. Lavigne CM, Shrier DA, Ketkar M et al. Tacrolimus leukoencephalopathy: a neuropathologic confirmation. Neurology 2004; 63: 1132-1133.
47. Metzler C, Lamprecht P, Hellmich B et al. Leucoencephalopathy after treatment of Churg-Strauss syndrome with interferon α. Ann Rheum Dis 2005; 64: 1242-1243.
48. Perico N, Remuzzi G. Edema of the nephrotic syndrome: the role of the atrial peptide system. Am J Kidney Dis 1993; 22(3): 355-356.
49. Jennekens FGI, Kater L. The central nervous system in systemic lupus erythematosus. Part 2. Pathogenetic mechanisms of clinical syndromes: a literature investigation. Rheumatology 2002; 41: 619-630.
50. Abbott NJ, Mendonca LLF, Dolman DEM. The blood-brain barrier in systemic lupus erythematosus. Lupus 2003; 12: 908-915.
51. Meroni PL, Tincani A, Sepp N et al. Endothelium and the brain in CNS lupus. Lupus 2003; 12: 919-928.